Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
Recruiting · NCT06555133 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC | Colorectal Carcinoma Metastatic in the Liver | Recruiting | Phase 2 | 2026-08-20 | NCT06555133 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brown University | 104 |
| Genentech, Inc. | 221 |
| Sirtex Medical | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals Providence, Rhode Island, United States, 02903 Contact: | Providence | United States | 1 |